bpc-157 cuprizone demyelination model Berberine to treat multiple sclerosis Inflammatory and progressive neurodegeneration are characteristics of multiple sclerosis (MS). Current treatments primarily mitigate relapses and slow disease progression and do not address the Strength:10ml BPC-157 (Body Protection Compound 5 AMINO 1MQ
Pay in 4 interest-free payments of $7.16 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Sep 16 - Sep 21